Primary care follow-up of the neonatal intensive care unit graduate

Clinics in Family Practice

Volumn 5, Issue 2, 2003, Pages 243-263

  Marshall, Diane D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; DIURETIC AGENT; FUROSEMIDE; OXYGEN; STEROID;

ANAMNESIS; CHILD CARE; COMMUNITY; ELECTROLYTE DISTURBANCE; FAMILY; FOLLOW UP; GROWTH DISORDER; GROWTH RETARDATION; HEART ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HOSPITAL DISCHARGE; HUMAN; HYPERCALCIURIA; HYPERTENSION; HYPOXEMIA; INFANT; KIDNEY CALCIFICATION; LUNG DYSPLASIA; LUNG EDEMA; MEDICAL SPECIALIST; METABOLIC ALKALOSIS; MORBIDITY; NEUROLOGIC DISEASE; NEWBORN INTENSIVE CARE; NUTRITIONAL DEFICIENCY; OSTEOPENIA; PREMATURITY; PRIMARY MEDICAL CARE; REVIEW; RISK FACTOR; SENSORY DYSFUNCTION;

EID: 0038637201     PISSN: 15225720     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-5720(03)00015-1     Document Type: Review

References (75)

1. Hoyert DL, Freedman MA, Strobino DM, et al. Annual summary of vital statistics: 2000. Pediatrics 2001;108:1241-5.
2. Costeloe K, Hennessy E, Gibson AT, et al For the EPICure Study Group. The EPICure Study: Outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000;106:659-71.
3. Hack M, Friedman H, Fanaroff AA. Outcomes of extremely low birth weight infants. Pediatrics 1996;98:931-7.
4. Wood NS, Marlow N, Costeloe K, et al, for the EPICure Study Group. Neurologic and developmental disability after extremely preterm birth. N Engl J Med 2000;343:378-84.
5. Silva DT, Hagan R, Sly PD. Home oxygen management of neonatal chronic lung disease in Western Australia. J Paediatr Child Health 1995;31:185-8.
6. AAP Committee on Fetus and Newborn. Hospital discharge of the high-risk neonate: proposed guidelines (RE9812). Pediatrics 1998;102:411-7.
7. Ehrenkranz RA, Younes N, Lemons JA, et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics 1999;104:280-9.
8. Casey P, Kraemer HC, Bernbaum J, et al. Growth status and growth rates of a varied sample of low birthweight, preterm infants: a longitudinal cohort from birth to three years of age. J Pediatr 1991;119:599-605.
9. Carver JD, Wu PYK, Hall RT, et al. Growth of preterm infants fed nutrient-enriched or term formula after hospital discharge. Pediatrics 2001;107:683-9.
10. Theriot L. Routine nutrition care during follow-up. In: Groh-Wargo S, Thompson M, Cox JH, Hartline J, editors. Nutritional care for high-risk newborns. Chicago: Precept Press; 2000. p. 567-83.
11. Guo SS, Roche AF, Chumlea WC, et al. Growth in weight, recumbent length, and head circumference for preterm low-birth-weight infants during the first three years of life using gestation-adjusted ages. Early Hum Dev 1997;47:305-25.
12. Carlson SJ, Ziegler EE. Nutrient intakes and growth of very low birth weight infants. J Perinatol 1998;18:252-8.
13. Greer FR. Feeding the preterm infant after hospital discharge. Pediatr Ann 2001;30: 658-65.
14. Chan GM. Growth and bone mineral status of discharged very low birthweight infants fed different formulas or human milk. J Pediatr 1993;123:439-43.
15. Hall RT. Nutritional follow-up of the breastfeeding premature infant after hospital discharge. Pediatr Clin North Am 2001;48:453-60.
16. Hall RT, Wheeler RE, Rippetoe LE. Calcium and phosphorus supplementation after initial hospital discharge in breast-fed infants at less than 1800 grams birthweight. J Perinatol 1993;13:272-8.
17. Cox JH, Doorlag D. Nutritional concerns at transfer or discharge. In: Groh-Wargo S, Thompson M, Cox JH, Hartline J, editors. Nutritional care for high-risk newborns. Chicago: Precept Press. 2000. p. 549-65.
18. Worrell LA, Thorpe JW, Tucker R, et al. The effects of the introduction of a high-nutrient transitional formula on growth and development of very-low-birth-weight infants. J Perinatol 2002;22:112-9.
19. Barrington KJ, Tan K, Roch W. Apnea at discharge and gastro-esophageal reflux in the preterm infant. J Perinatol 2002;22:8-11.
20. Orenstein SR. Infantile reflux: different from adult reflux. Am J Med 1997;103:1145-95.
21. Jadcherla SR. Gastroesophageal reflux in the neonate. Clin Perinatol 2002;29:135-58.
22. Hassell E. Wrap session: Is the Nissen slipping? Can medical treatment replace surgery for severe gastroesophageal disease in children? Am J Gastroenterol 1995;90:1212-20.
23. Attias D. Pathophysiology and treatment of anemia of prematurity. J Pediatr Hematol Oncol 1995;17:13-8.
24. Strauss RG. Red blood cell transfusion practices in the neonate. Clin Perinatol 1995;22:641-55.
25. Alverson DC. The physiologic impact of anemia in the neonate. Clin Perinatol 1995; 22:609-25.
26. Bard H, Fouron JC, Chessex P, et al. Myocardial, erythropoietic and metabolic adaptations to anemia of prematurity in infants with bronchopulmonary dysplasia. J Pediatr 1998;132:630-4.
27. Lachance C, Chessex P, Fouron JC, et al. Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity. J Pediatr 1994;125:278-82.
28. American Academy of Pediatrics Committee on Nutrition. Nutritional needs of preterm infants. Pediatric nutrition handbook. 4th edition. Elk Grove Village (IL): AAP; 1998.
29. Eichenwald EC, Aina A, Stark AR. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics 1997;100:354-9.
30. National Institutes of Health Consensus Development Conference on Infantile Apnea and Home Monitoring. September 29 October 1, 1986. Pediatrics 1987;79:292-9.
31. American Academy of Pediatrics Task Force on Newborn and Infant Hearing. Newborn and infant hearing loss: detection and intervention. Pediatrics 1999;103:527-30.
32. Joint Committee on Infant Hearing. Year 2000 Position Statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics 2000; 106:798-817.
33. Cone-Wesson B, Vohr BR, Sininger YS, et al. Identification of neonatal hearing impairment: infants with hearing loss. Ear Hear 2000;21:488-507.
34. Roizen NJ. Etiology of hearing loss in children: nongenetic causes. Pediatr Clin North Am 1999;46:49-64.
35. White KR, Vohr BR, Behrens TR. Universal newborn hearing screening using transient evoked otoacoustic emissions: results of the Rhode Island Hearing Assessment Project. Semin Hearing 1993;14:18-29.
36. Finitzo T, Albright K, O'Neal J. The newborn with hearing loss: detection in the nursery. Pediatrics 1998;102:1452-60.
37. Mann T, Adams K. Sensorineural hearing loss in ECMO survivors: extracorpororeal membranous oxygenation. J Am Acad Audiol 1998;9:367-70.
38. Walton JP, Hendricks-Munoz K. Profile and stability of sensorineural hearing loss in persistent pulmonary hypertension of the newborn. J Speech Hear Res 1991;34:1362-70.
39. Williamson WD, Demmler GJ, Percy AK, et al. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 1992;90:862-6.
40. Cryotherapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of premature birth and retinopathy: status at 1 year. Arch Ophthalmol 1994;112:903-12.
41. American Academy of Pediatrics. American Association for Pediatric Ophthalmology and Strabismus, American Academy of Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2001;108:809-11.
42. Phelps DL. Retinopathy of prematurity. Pediatr Rev 1995;16:50-5.
43. Atkinson WL, Pickering LK, Schwartz B, et al. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR 2002;51:1-36.
44. American Academy of Pediatrics Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention. Recommended childhood immunization schedule: United States, 2002. Pediatrics 2002;109:162.
45. Lau YL, Tam AY, Ng KW, et al. Response of preterm infants to hepatitis B vaccine. J Pediatr 1992;121:962-5.
46. Kim SC, Chung EK, Hodinka RL, et al. Immunogenicity of hepatitis B vaccine in preterm infants. Pediatrics 1997;99:534-6.
47. Losonsky GA, Wasserman SS, Stephens I, et al. Vaccination of premature infants: a reassessment of current recommendations for delayed immunization. Pediatrics 1999; 103:E14.
48. Patel DM, Butler J, Feldman S, et al. Immunogenicity of hepatitis B vaccine in healthy very low birth weight infants. J Pediatr 1997;131:641-3.
49. Committee on Infectious Diseases, American Academy of Pediatrics. Red Book, Report of the Committee on Infectious Diseases. 25th edition. Elk Grove Village (IL): AAP; 2000.
50. The IMPACT RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization for respiratory syncytial virus in high-risk infants. Pediatrics 1998;102:531-7.
51. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Fetus and Newborn. Prevention of respiratory syncytial virus infections: indications for the use of Palivizumab and update on the use of RSV-IGIV (RE9839). Pediatrics 1998;102:1211-6.
52. Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 2000;105:1216-25.
53. Gregoire M, LeFebvre F, Glorieux J. Health and developmental outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia. Pediatrics 1998;101:856-60.
54. Shennan AT, Dunn MS, Ohlsson A, et al. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82:527-32.
55. Groothius JR, Rosenberg AA. Home oxygen promotes weight gain in infants with BPD. Am J Dis Child 1987;141:992-5.
56. Moyer-Milleur LJ, Nielson DW, Pfeefer KD, et al. Eliminating sleep associated hypoxemia improves growth in infants with bronchopulmonary dysplasia. Pediatrics 1996;98:779-83.
57. Kotecha S, Allen J. Oxygen therapy for infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2002;87:F11-4.
58. Halliday HL, Dumpit FM, Brady JP. Effects of inspired oxygen on echocardiographic assessment of pulmonary vascular resistance and myocardial contractility in BPD. Pediatrics 1980;65:536-40.
59. Abman SH, Wolfe RR, Accurso FJ, et al. Pulmonary vascular response to oxygen in infants with severe BPD. Pediatrics 1985;75:80-4.
60. Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia. Current Issues. Pediatr Clin North Am 1994;41:277-315.
61. Kao LC, Durand DJ, McCrea RC, et al. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia. J Pediatr 1994;124:772-81.
62. Kao LC, Warburton D, Sargent CW, et al. Furosemide acutely decreases airways resistance in chronic bronchopulmonary dysplasia. J Pediatr 1983;103:624-9.
63. Rush MG, Hazinski TA. Current therapy of bronchopulmonary dysplasia. Clin Perinatol 1992;19:563-90.
64. Sweet DG, Halliday HL. A risk benefit assessment of drugs used for neonatal chronic lung disease. Drug Saf 2000;22:389-404.
65. Rush MG, Englehardt B, Parker RA, et al. Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasia. J Pediatr 1990;117:112-8.
66. O'Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcomes of study participants at 1-year adjusted age. Pediatrics 1999;104:15-21.
67. Ng PG, Blackburn ME, Bramlee KG, et al. Adrenal response in very low birthweight babies after dexamethasone treatment for BPD. Arch Dis Child 1989;64:1721-6.
68. Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 2002;87:F15-8.
69. Orenstein SR, Orenstein DM. Gastroesophageal reflux and respiratory disease in children. J Pediatr 1988;112:847-57.
70. Schmidt B, Davis P, Moddemann D, et al, for the Trial of Indomethacin Prophylaxis in Preterm Investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. New Engl J Med 2001;344:1966-72.
71. Gross SJ, Mettleman BB, Dye TD, et al. Impact of family structure and stability on academic outcome in preterm children at 10 years of age. J Pediatr 2001;138:169-75.
72. Perlman JM. Neurobehavioral deficits in premature graduates of intensive care: potential medical and neonatal environmental risk factors. Pediatrics 2001;108:1339-48.
73. Roth SC, Baudin J, McCormick DC, et al. Relation between ultrasound appearance of the brain of very preterm infants and neurodevelopmental impairment at eight years. Dev Med Child Neurol 1993;35:755-68.
74. Infants Health and Development Program. Enhancing the outcomes of low-birth weight premature infants: a multisite, randomized trial. JAMA 1990;263:3035-42.
75. Rossetti LM. Communication intervention, birth to three. 2nd edition. Australia: Singular, Thomson Learning; 2001.